Clinical Trial

Coronary Artery Disease and Coronary Microvascular Disease in Cardiomyopathies Registry

Study acronym: 3CRegistry
Recruiting
View on ClinicalTrials.gov →
Summary
Long-term prognostic value of macrovascular and microvascular coronary artery stenoses in each type of cardiomyopathy.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2018-03-20; most recent amendment 2022-05-18.
Trial Details
NCT Number NCT03479580
Lead Sponsor University Hospital, Grenoble
Collaborators: Clinique Belledonne, Groupe Hospitalier Mutualiste de Grenoble, Centre Hospitalier Annecy Genevois, Centre Hospitalier Metropole Savoie
Conditions Hypertrophic, Ischemic, Restrictive Cardiomyopathy, Dilated Cardiomyopathies
Enrollment 1,600 participants
Start Date 2018-02-08
Primary Completion 2028-02 (estimated)
Study Completion 2028-02 (estimated)
Updated on ClinicalTrials.gov 2022-05-19